
Key Takeaways
- scRNA-seq resolves immune subsets and activation states that bulk sequencing averages together.
- Trajectory analysis can describe how progenitors differentiate toward immune lineages.
- Combining scRNA-seq with genetic data can link disease risk variants to specific immune cell types.
- Dissociation-based scRNA-seq loses the location of immune cells within tissue.
- Sample handling, viability, and contamination control strongly affect data quality.
How scRNA-seq Works
A typical workflow includes four stages:
- Cell isolation: separating individual cells from blood or dissociated tissue.
- Library preparation: introducing cell-specific identifiers during cell capture or library construction so sequencing reads can be assigned back to their cell of origin; the exact barcoding strategy depends on the platform.
- Sequencing: generating transcript reads.
- Computational analysis: clustering cells by expression and annotating them with marker genes and reference datasets.
Peripheral blood mononuclear cells (PBMCs) are a common starting material because they can be collected with minimal dissociation. Tissue-resident immune cells require enzymatic or mechanical dissociation, which can alter expression.

Why Immune Cells Benefit From Single-Cell Resolution
Immune samples contain many cell types and states in the same specimen:
- T cells, including many functional subsets
- B cells and plasma cells
- NK cells
- Monocytes and macrophages
- Dendritic cells
Many of these populations share markers or shift between activation states. scRNA-seq profiles each cell separately, which allows subsets to be distinguished by combinations of expressed genes.
What scRNA-seq Has Been Used to Study
Genetic Effects Specific to Immune Cell Types
A 2022 study in Science profiled 1,267,758 PBMCs from 982 donors in the OneK1K cohort (Yazar et al., 2022). The authors mapped genetic effects on gene expression that were specific to individual immune cell types. This type of analysis links disease-associated variants to the cell types in which they act.
Immune Cell Differentiation
Trajectory, or pseudotime, analysis orders cells along inferred developmental paths. It has been used to describe how hematopoietic stem and progenitor cells diverge toward erythroid, myeloid, and lymphoid lineages. Trajectories are computational inferences and are typically supported with lineage tracing or functional assays.
Infection and Autoimmune Disease
scRNA-seq studies have compared immune cell composition and expression between patients and controls in infections and autoimmune diseases. Reported changes include shifts in monocyte and macrophage states and in inflammatory gene expression. Results depend on cohort size, disease stage, and tissue sampled, so they are usually validated in independent cohorts.
Cancer Immunology
In tumors, scRNA-seq is used to characterize T-cell activation and exhaustion states, myeloid populations, and their association with treatment response. These findings support research on immunotherapy mechanisms and biomarkers.
The Role of Tissue Context
Dissociation-based scRNA-seq does not retain where each cell was located. For immune cells, location can matter. A T cell inside a tumor nest may differ from one in the surrounding stroma, and immune aggregates may have distinct organization.
Several approaches add spatial information:
- Spatial transcriptomics measures expression within intact sections.
- Multiplexed imaging maps immune protein markers in tissue.
- Laser capture microdissection (LCM) isolates selected immune-rich regions or visually identifiable cells from tissue sections for targeted downstream molecular analysis.
LCM is a microscopy-guided tissue-isolation method rather than a replacement for high-throughput scRNA-seq. It can preserve the link between captured material and tissue morphology, making it useful for spatially defined follow-up of regions such as lymphoid aggregates or tumor margins.
Sample Preparation Considerations
- Viability: dead cells release RNA that can contaminate other cells' profiles. Viability staining helps assess sample quality.
- Dissociation effects: enzymatic digestion can induce stress-related genes, which can be mistaken for activation signatures.
- Doublets: two cells captured together can resemble an intermediate cell type. Sample multiplexing and computational tools help identify them.
- Batch effects: samples processed at different times or sites can differ for technical reasons. Balanced study design reduces this risk.
Laxco Accuva Cellect for Region-Specific Immune Studies
Researchers who need expression data from immune cells in a defined tissue region may consider LCM. Laxco's Accuva Cellect Laser Capture Microdissection System is designed for this:
- Infrared (IR) laser: designed for capture of single cells or small numbers of cells.
- UV laser: designed for cutting dense structures, such as bone or plant tissue.
- Sample preparation: Laxco lists FFPE and fresh-frozen tissue, H&E-stained and LCM-optimized stains, immunofluorescence, unstained samples, and cell culture.
- Software workflow: a five-step workflow supports target selection, visual quality control, and documentation.
Immunofluorescence staining can be used to identify immune cell types before capture, provided the staining protocol is compatible with RNA preservation. Laxco provides application training and technical support and does not perform sequencing as a laboratory service.
Frequently Asked Questions
Can LCM capture immune cells identified by immunofluorescence?
Yes. Laxco lists immunofluorescence among the preparations supported by Accuva Cellect. Use rapid, RNase-controlled staining so that RNA quality remains suitable for expression analysis after capture. Pilot sections help confirm that marker signal and RNA integrity are both adequate.
How do scRNA-seq and LCM serve different roles in immune-tissue studies?
scRNA-seq is suited to profiling many dissociated cells and resolving transcriptional states across a population. LCM is suited to morphology- or location-guided isolation of selected cells or tissue regions for targeted downstream analysis. The methods can be complementary when a study needs broad single-cell profiling together with spatially defined follow-up.
How can I reduce stress signatures from tissue dissociation?
Use a dissociation method validated for the tissue and assay. Where compatible, cold-active protease workflows can reduce stress-induced transcriptional artifacts compared with conventional warm digestion. Fixation can also preserve transcriptional state, but only when the downstream single-cell chemistry explicitly supports the chosen fixation method. Minimize unnecessary processing delays and perform platform-appropriate cell-quality checks before loading.
Can Accuva Cellect capture single immune cells?
Laxco describes the Accuva Cellect infrared laser as designed for capture of single cells or small numbers of cells. Detection from one cell depends on the sensitivity of your RNA amplification and library method.
What training is available for new Accuva Cellect users?
Laxco lists training and 48-hour response times as part of its Accuva Cellect support offering. Confirm available training formats and application-specific guidance directly with Laxco when planning immunofluorescence-guided LCM workflows.